Shree Ganesh Remedies' Q4 FY 2025-26 Quarterly Results

Result Summary

• Shree Ganesh Remedies Ltd reported a 57.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 28.1%.
• Its expenses for the quarter were up by 43.3% QoQ and 42.1% YoY.
• The net profit increased 102.9% QoQ and decreased 4.9% YoY.
• The earnings per share (EPS) of Shree Ganesh Remedies Ltd stood at 4.88 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Shree Ganesh Remedies Ltd is a company that operates in the chemical and pharmaceutical industry. It is primarily involved in the manufacturing of fine chemicals, which are used as raw materials, intermediates, or active pharmaceutical ingredients (APIs) in various pharmaceuticals. The company's portfolio includes a range of chemical compounds that cater to the needs of the pharmaceutical sector. As of the latest updates, any recent major developments or strategic changes in the company are not available. The company has been focused on innovation and expanding its product offerings to meet the evolving demands of the pharmaceutical industry.

Revenue

In the fourth quarter of FY26, Shree Ganesh Remedies Ltd reported a total income of ₹34.22 crores, a notable increase from ₹21.76 crores in the third quarter of FY26. This represents a quarter-over-quarter (QoQ) growth of 57.3%. Compared to the same quarter in the previous fiscal year (Q4FY25), where the total income was ₹26.72 crores, there was a year-over-year (YoY) increase of 28.1%. This growth in revenue suggests a strong performance in the latest quarter, potentially driven by increased sales volume or higher pricing strategies. The revenue growth indicates a positive trend in the company's financial performance over both the quarter and the year.

Profitability

Profit before tax for Q4FY26 was recorded at ₹8.72 crores, showing a substantial QoQ increase of 119.1% from ₹3.98 crores in Q3FY26. However, when compared to Q4FY25, where the profit before tax was ₹8.77 crores, there is a slight YoY decrease of 0.6%. The tax expense for the same period was ₹2.45 crores, which also saw a significant QoQ rise of 175.3% from ₹0.89 crores in Q3FY26, and a YoY increase of 12.4% from ₹2.18 crores in Q4FY25. Consequently, the profit after tax for Q4FY26 amounted to ₹6.27 crores, marking a 102.9% QoQ growth from ₹3.09 crores in Q3FY26, but a YoY decline of 4.9% from ₹6.59 crores in Q4FY25. The earnings per share (EPS) mirrored this trend, increasing QoQ by 102.5% to ₹4.88 but decreasing YoY by 4.9% from ₹5.13.

Operating Metrics

Total expenses for Q4FY26 were ₹25.50 crores, representing a 43.3% increase from ₹17.79 crores in Q3FY26, and a 42.1% rise from ₹17.94 crores in Q4FY25. This escalation in expenses could be attributed to higher production costs or increased operational expenditures. The company's operating performance, as reflected in the financial data, shows a notable increase in both income and expenses over the quarters and year, suggesting changes in operational scale or efficiency. There are no specific financial ratios or additional operating metrics such as P/E ratio, debt-to-equity ratio, or current ratio provided in the available data for an in-depth analysis.